This unit entry is for students who completed this unit in 2016 only. For students planning to study the unit, please refer to the unit indexes in the the current edition of the Handbook. If you have any queries contact the managing faculty for your course or area of study.

PSC3221 - Biomolecule formulation & modified release technologies

6 points, SCA Band 2, 0.125 EFTSL

Undergraduate - Unit

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered.

Faculty

Pharmacy and Pharmaceutical Sciences

Coordinator(s)

Professor Colin Pouton

Offered

Parkville

First semester 2016 (Day)

Synopsis

One aim of this unit is to improve student skills in information literacy and scientific writing. The second aim is for students to identify and research issues and questions to develop their knowledge of biomolecular pharmaceutical products. Students will undertake literature searches addressing the manufacture, purification and formulation of these products. The unit is compatible with Monash University's goals for research lead teaching.

Outcomes

At the end of this unit students will be able to:

Explain the steps involved in industrial-scale cell culture mediated production and purification of a recombinant protein pharmaceutical active
Describe the structure and function of excipients required for formulation of biomolecules
Design a formulated biomolecular pharmaceutical product

Assessment

Online modules (and reports) 10% each (20%); Individual assignment 20%, oral presentation 10%; Written assignment report 50%

Workload requirements

Contact hours for on-campus students:

Twenty-four 1-hour lectures
Six 1-hour tutorials/workshops

Chief examiner(s)

Professor Colin Pouton

Prerequisites

PSC2041 Biopharmaceutics

Additional information on this unit is available from the faculty at:

http://www.monash.edu/pharm/current/